Related by context. All words. (Click for frequent words.) 78 Bevacizumab 76 Pertuzumab 75 Irinotecan 75 Bortezomib 75 Erlotinib 74 trastuzumab Herceptin 74 Taxotere ® 74 pegylated liposomal doxorubicin 74 Pemetrexed 74 Dasatinib 74 DOXIL 74 Lenalidomide 73 Paraplatin ® 73 Fludarabine 73 Neoadjuvant 73 Pegylated Interferon 73 Gemcitabine 73 bevacizumab Avastin 73 Adjuvant Therapy 73 Rituximab 73 imatinib Gleevec 73 pertuzumab 73 thalidomide Thalomid 72 Alemtuzumab 72 Peginterferon 72 cetuximab Erbitux ® 72 bevacizumab Avastin ® 72 erlotinib Tarceva ® 72 pegfilgrastim 72 Taxol ® 72 TYKERB 72 decitabine 72 docetaxel Taxotere ® 72 Neulasta ® 72 Capecitabine 72 Monotherapy 72 alpha 2a 72 gefitinib Iressa 71 Blinatumomab 71 Fulvestrant 71 ixabepilone 71 rituximab Rituxan 71 FOLFIRI 71 rhIL 7 71 Metastatic Colorectal Cancer 71 Natalizumab 71 Decitabine 71 Exemestane 71 sorafenib Nexavar 71 YONDELIS 71 gemcitabine Gemzar 71 Pegylated 71 Herceptin trastuzumab 71 Cisplatin 71 Fludara ® 71 Aliskiren 71 Temsirolimus 71 Doxil ® 71 Docetaxel 71 Vandetanib 71 Traficet EN 70 Interferon beta 1a 70 Sorafenib 70 metastatic malignant 70 EGFR TKI 70 Amrubicin 70 paclitaxel Taxol ® 70 paclitaxel Taxol 70 TNF Tumor Necrosis Factor 70 Hormone Refractory Prostate Cancer 70 Aflibercept 70 AVASTIN 70 Fluorouracil 70 HER2 positive metastatic breast 70 Degarelix 70 Advanced Renal Cell 70 Everolimus 70 APTIVUS r 70 luteinizing hormone releasing 70 Adjuvant Treatment 70 IRESSA 70 paclitaxel Taxol R 70 Prolongs Survival 70 Disease Progression 70 lapatinib Tykerb 70 CHOP chemotherapy 70 CoFactor 70 Antitumor Activity 70 tyrosine kinase inhibitor 70 cetuximab Erbitux R 70 Doxorubicin 70 gastrointestinal stromal tumors GIST 70 DAVANAT 70 APTIVUS R 70 Gefitinib 70 Melphalan 70 ZOLINZA 70 imatinib Gleevec ® 70 Mitoxantrone 69 Metastatic Renal Cell Carcinoma 69 nilotinib Tasigna 69 PSMA ADC 69 rilonacept 69 LHRH 69 lenalidomide Revlimid R 69 Alocrest 69 VAPRISOL 69 GW# [003] 69 Imatinib 69 alefacept 69 Voreloxin 69 Renal Cell Carcinoma 69 Elotuzumab 69 Complicated Skin 69 standard chemotherapy regimen 69 nucleoside analog 69 idarubicin 69 EGFr 69 FASLODEX 69 gemcitabine carboplatin 69 Metastatic Prostate Cancer 69 erlotinib Tarceva 69 Chemoradiation 69 Liposomal 69 Epratuzumab 69 liposomal formulation 69 Gleevec resistant 69 sorafenib tablets 69 Eculizumab 69 proteasome inhibitor bortezomib 69 Anthracycline 69 angiogenesis inhibitor 69 Lubiprostone 69 Cutaneous T 69 azacitidine 69 Zorbtive TM 69 Pegasys ® 69 biologic therapy 69 HER2 Positive Breast Cancer 69 Survival Benefit 69 sunitinib Sutent ® 69 Pegylated Liposomal Doxorubicin 69 CANCIDAS 69 Bezielle 69 CYT# potent vascular disrupting 69 dasatinib Sprycel 69 PEG SN# 69 pan HDAC inhibitor 69 Carboplatin 69 HuMax CD4 69 CCX# 69 ganetespib 69 alfa 2a 69 corticosteroid dexamethasone 69 ZD# [001] 69 Glufosfamide 69 Gemzar ® 69 EGFR inhibitors 69 cidofovir 69 Platinol ® 69 sunitinib malate 69 Aptivus ® 69 ribavirin RBV 69 Previously Untreated 69 ACE Inhibitors 69 Copegus ribavirin 69 Anti Tumor Activity 69 Tiotropium 69 AMEVIVE 69 Dapagliflozin 69 Adjuvant Chemotherapy 69 PKC# 69 MYCAMINE 68 Meets Primary Endpoint 68 Cardiotoxicity 68 mRCC 68 adalimumab Humira 68 Autologous Stem Cell Transplantation 68 Zolinza 68 5 Fluorouracil 68 Camptosar ® 68 MGd 68 DAPT 68 Radioimmunotherapy 68 chemotherapy docetaxel 68 Trastuzumab Herceptin 68 trastuzumab Herceptin ® 68 dasatinib Sprycel ® 68 ritonavir boosted 68 Anti Tumor 68 etoposide 68 Etanercept 68 Advanced Melanoma 68 alkylating agent 68 multitargeted 68 gemcitabine cisplatin 68 Anti TNF 68 FOLFOX6 68 exemestane Aromasin 68 uric acid lowering 68 CA4P 68 TAXOTERE R 68 trabectedin 68 Nexavar ® 68 Golimumab 68 HuLuc# 68 Adalimumab 68 Nilotinib 68 clodronate 68 Epidermal Growth Factor Receptor 68 Posaconazole 68 Aurora Kinase 68 Oxaliplatin 68 YERVOY 68 etanercept Enbrel 68 IMA# 68 HuMax EGFr 68 relapsed MM 68 CIMZIA ™ 68 Fludara 68 PEGylated anti 68 MabCampath 68 Taxotere docetaxel 68 Well Tolerated 68 Lamotrigine 68 T#I [002] 68 Vidofludimus 68 trastuzumab 68 CD# antibody [001] 68 icatibant 68 Boceprevir 68 temsirolimus Torisel ® 68 tanespimycin 68 Tyrosine Kinase Inhibitor 68 Androgen Deprivation Therapy 68 Allogeneic 68 Trabectedin 68 anti angiogenic agent 68 Lapatinib 68 anakinra 68 Bosutinib 68 infliximab Remicade 68 Leukine ® 68 BAY #-# 68 MAGE A3 ASCI 68 liposomal doxorubicin 68 Intravesical 68 docetaxel chemotherapy 68 Xelox 68 goserelin 68 cinacalcet 68 REVLIMID R 68 recurrent glioblastoma multiforme 68 Phase 2b Clinical Trial 68 proteasome inhibitor 68 LEUKINE 68 Hepatocellular Carcinoma 68 metastatic CRC 68 XYOTAX TM 68 REYATAZ R 68 5 fluorouracil leucovorin 68 Malignant Melanoma 68 Gleevec imatinib mesylate 68 PEGylated Fab fragment 68 oblimersen 68 Platinol ® cisplatin 68 LHRH agonist 68 ara C 68 interferon alfa 68 daunorubicin 68 Amplimexon 68 DFMO 68 Cyclophosphamide 68 Tacrolimus 68 mu opioid receptor antagonist 68 Azacitidine 68 Combination Therapy 68 interferon IFN 68 metastatic renal cell carcinoma 68 Tumor Necrosis Factor 68 Azedra 68 Vidaza azacitidine 68 Pralatrexate 68 Panitumumab 68 Acute Ischemic Stroke 68 Peginterferon alfa 2b 68 ribavirin Copegus ® 68 cetuximab Erbitux 68 myelofibrosis polycythemia vera 67 Sym# 67 BRAF inhibitor 67 malignant ascites 67 5FU 67 Fondaparinux 67 octreotide 67 carboplatin paclitaxel 67 pemetrexed 67 Xanafide 67 tocilizumab 67 ONCASPAR 67 abacavir Ziagen 67 teriflunomide 67 Velcade bortezomib 67 Interferon alfa 67 Is Well Tolerated 67 VIDAZA 67 5 FU leucovorin 67 IL# PE#QQR 67 neoadjuvant chemotherapy 67 Interferon beta 67 Gastrointestinal Stromal Tumors 67 plus DOXIL 67 Follicular Lymphoma 67 SPRYCEL ® 67 cyclophosphamide methotrexate 67 ULORIC 67 Patients Treated With 67 dacarbazine 67 Noxafil 67 mycophenolate mofetil 67 Etoposide 67 Vorinostat 67 Castration Resistant Prostate Cancer 67 GAMMAGARD LIQUID 67 APTIVUS 67 TO AVOID PREGNANCY WHILE 67 Improves Survival 67 Nucleoside 67 cisplatin chemotherapy 67 Improved Survival 67 FIRMAGON 67 Quinamed 67 CIMZIA TM 67 Investigational Agent 67 Fluconazole 67 Imprime PGG 67 fluorouracil 67 Copegus ® 67 Phase IIb Trial 67 pemetrexed Alimta 67 Interferon alpha 67 bortezomib Velcade 67 cediranib 67 Valsartan 67 Ibritumomab Tiuxetan 67 Cetuximab Erbitux 67 Squalamine 67 Relapsed Refractory 67 AZT zidovudine Retrovir 67 Pazopanib 67 Newly Diagnosed Multiple Myeloma 67 Bevacizumab Avastin 67 oxaliplatin Eloxatin 67 cilengitide 67 bevacizumab Avastin R 67 topotecan 67 CAELYX 67 cell lymphoma CTCL 67 tigecycline 67 Panzem R NCD 67 Tarceva TM 67 Pharmacokinetics PK 67 Hycamtin 67 panitumumab Vectibix 67 INCB# [001] 67 sipuleucel T 67 Pfizer Sutent 67 vorinostat 67 imatinib mesylate Gleevec 67 Marqibo TM 67 chimeric monoclonal antibody 67 antimetabolite 67 Tocilizumab 67 letrozole Femara 67 protease inhibitor PI 67 azacytidine 67 somatostatin analogue 67 Procoralan 67 Xeloda ® 67 5-FU/LV 67 relapsed multiple myeloma 67 BAL# [002] 67 fulvestrant 67 Carfilzomib 67 Sipuleucel T 67 Chemophase 67 Pharmacokinetic Study 67 targeting CD# 67 Sapacitabine 67 Antiangiogenic 67 TEMODAL 67 evaluating tivozanib 67 Symadex 67 Cytoxan 67 voriconazole 67 tiuxetan 67 humanized anti 67 Moxifloxacin 67 Chronic Myeloid Leukemia 67 seliciclib 67 Tarvacin 67 Aplidin 67 mTOR inhibitor 67 nilotinib 67 Tumor Response 67 Tanespimycin 67 efalizumab 67 Medoxomil 67 HER2 receptor 67 FUSILEV enhances 67 receptor tyrosine kinase inhibitor 67 vWF 67 PEG IFN 67 vandetanib 67 BARACLUDE ® 67 Glatiramer Acetate 67 LHRH agonists 67 mapatumumab 67 NXL# 67 bleomycin 67 XELOX 66 ISTODAX 66 Topotecan 66 Targretin 66 targeted antifolate 66 factor Xa 66 MyVax R 66 Epoetin Alfa 66 Tesetaxel 66 ELOXATIN 66 Myelodysplastic Syndromes 66 galiximab 66 ZEVALIN ® 66 HuMax 66 Mitomycin C 66 oral prodrug 66 glatiramer 66 vidofludimus 66 Kepivance 66 fosbretabulin 66 pimozide 66 Pegylated interferon 66 Clolar ® 66 Zoledronic Acid 66 Metastatic Melanoma 66 orally dosed 66 GRASPA ® 66 Anastrozole 66 Vfend 66 Immunotherapeutic 66 Torisel 66 mitoxantrone 66 enzastaurin 66 docetaxel Taxotere R 66 infusional 66 Alkeran 66 Efficacious 66 sargramostim 66 Solid Tumors 66 bendamustine 66 DACH platinum 66 Recombinant Human 66 Vaprisol 66 PEGASYS ® 66 glatiramer acetate 66 Soft Tissue Sarcoma 66 Kinase Inhibitor 66 TYZEKA 66 Bosentan 66 peginterferon alfa 2a Pegasys 66 Fluticasone 66 verteporfin 66 IFN α 66 entecavir 66 docetaxel Taxotere 66 lenalidomide dexamethasone 66 Epirubicin 66 Betaferon R 66 Advanced Prostate Cancer 66 Gliadel Wafer 66 EndoTAG TM -1 66 Cetuximab 66 AVONEX ® 66 nab paclitaxel 66 BENICAR HCT 66 factor G CSF 66 Carvedilol 66 vinorelbine 66 colony stimulating factor 66 Colorectal Cancer Patients 66 Interferon Alfa 66 Tipranavir 66 Interferon Beta 66 chemoradiation therapy 66 Telbivudine 66 erlotinib Tarceva R 66 xanthine oxidase inhibitor 66 mertansine 66 metastatic castration resistant 66 STELARA TM 66 Romiplostim 66 Mipomersen 66 Peginterferon Alfa 2a 66 BANZEL 66 Potent Anti 66 Capesaris 66 humanized antibody 66 proteasome inhibitors 66 angiogenesis inhibition 66 Photodynamic therapy 66 IMC A# 66 cytotoxic therapy 66 Ocrelizumab 66 cisplatin carboplatin 66 refractory chronic lymphocytic 66 Inhalation Solution 66 Hsp# Inhibitor 66 pegylated interferon alfa 2a 66 pyrazinamide 66 Anthracyclines 66 Aplidin R 66 irbesartan 66 L asparaginase 66 temsirolimus 66 intravesical infusion therapy 66 idraparinux 66 FLT3 66 Chronic Hepatitis C 66 metastatic malignant melanoma 66 Enzastaurin 66 herpetic keratitis 66 Tezampanel 66 Bendamustine 66 Hepatocellular Carcinoma HCC 66 invasive candidiasis 66 systemic antifungal 66 capecitabine Xeloda 66 INTELENCE 66 Clinical Outcome 66 SCCHN 66 Taxol paclitaxel 66 biologic DMARD 66 Radiofrequency Ablation RFA 66 ErbB2 positive 66 Chemokine Receptor 66 Lacosamide 66 Cilostazol 66 Navelbine ® 66 HQK 66 Malignant Glioma 66 temozolomide Temodar 66 stage IIIB 66 targeted radiotherapeutic 66 relapsed ovarian cancer 66 Benign Prostatic Hyperplasia 66 ibandronate 66 Omacetaxine 66 antiangiogenic therapy 66 Revlimid lenalidomide 66 XmAb# 66 JAK Inhibitor 66 pegylated interferons 66 Infliximab 66 Kinase Inhibitors 66 delafloxacin 66 Prostacyclin 66 chemoradiotherapy 66 Naive Patients 66 cabazitaxel 66 Factor VIIa 66 cetuximab 66 Anti VEGF 66 HERCEPTIN 66 LymphoStat B 66 meropenem 66 alpha 2b 66 KRAS mutation 66 Hycamtin ® 66 CD# monoclonal antibody 66 Rilonacept 66 refractory AML 66 MGCD# [001] 66 AEG# 66 chemotherapeutic drug 66 paclitaxel cisplatin 66 Estrogen Receptor 66 RhuDex ® 66 antiangiogenic 66 IgG1 antibody 66 cisplatin gemcitabine 66 Relapsing Remitting Multiple Sclerosis 66 Caelyx 66 viral kinetics 66 S#P# 66 Leukemias 66 TELINTRA 66 Vivaglobin 66 biliary tract cancer 66 denileukin diftitox 65 CONTRAINDICATIONS 65 Previously Treated 65 PEGINTRON TM 65 Patients Receiving 65 Phase 2b Study 65 relapsing multiple sclerosis 65 Interferon Alpha 65 melphalan prednisone 65 PEGPH# 65 Cimzia ® certolizumab pegol 65 Receptor Antagonists 65 protein kinase inhibitor 65 Abatacept 65 Oral Mucositis 65 fluoropyrimidine 65 TNF α 65 trans retinoic acid 65 Novel Inhibitor 65 Phase 2a Clinical Trial 65 vinca alkaloid 65 Imiquimod 65 SCIg 65 EGFR HER2 65 demethylating agent 65 ONTAK 65 epirubicin 65 trabedersen 65 immune modulatory 65 Hydroxyurea 65 COPEGUS R 65 tyrosine kinase inhibitors 65 sorafenib Nexavar ® 65 zidovudine AZT 65 pegylated interferon alfa 65 superficial bladder cancer 65 Overactive Bladder 65 Novel Oral 65 OHR/AVR# 65 estramustine 65 Single Dose 65 Bicalutamide 65 selective modulator 65 REYATAZ ® 65 3TC lamivudine Epivir 65 CYC# 65 FOLFOX chemotherapy 65 Severe Sepsis 65 tipranavir 65 interleukin IL -# 65 Cloretazine 65 Ranolazine 65 recombinant tissue plasminogen 65 chemotherapeutic regimen 65 oral Xeloda 65 HGS ETR2 65 leukemia AML 65 INTEGRILIN 65 Phase 2b Trial 65 thymalfasin 65 Cytarabine 65 Cell Lymphoma 65 metastatic neuroendocrine tumors 65 Antiviral Activity 65 R lenalidomide 65 FOLFOX4 65 itraconazole 65 Unfractionated Heparin 65 Enzyme Replacement Therapy 65 anti androgen 65 OXi# 65 Study Evaluating 65 BiTE 65 nucleoside analogues 65 Methylnaltrexone 65 Brain Metastases 65 Cimzia certolizumab pegol 65 Ranibizumab 65 mitomycin 65 LY# [003] 65 Yondelis ® 65 Rheumatoid Arthritis Patients 65 Adefovir 65 hA# 65 recurrent NSCLC 65 INTEGRILIN R 65 Unresectable 65 HDAC Inhibitor 65 Cytotoxic 65 Nexavar sorafenib 65 nitazoxanide 65 HGS ETR1 65 Exelixis XL# 65 FluCAM 65 dose cytarabine 65 CR# vcMMAE 65 SYN# 65 Ixempra 65 Intravenous CP 65 adriamycin 65 gefitinib 65 Ozarelix 65 atrasentan 65 olmesartan 65 Darunavir 65 panobinostat 65 Pulmonary Arterial Hypertension 65 chemotherapy cisplatin 65 PEG interferon 65 Myelodysplastic Syndrome MDS 65 Cloretazine VNP#M 65 FOLPI 65 ATL# [001] 65 combretastatin A4 phosphate CA4P 65 Panzem R 65 boosted protease inhibitor 65 interferon alfa 2b 65 Dose Escalation 65 Neupogen ® 65 OncoVEX GM CSF 65 Campath alemtuzumab 65 BEXXAR 65 antiplatelet agent 65 Antitumor 65 PRT# 65 Phase III Clinical Trial 65 Vinorelbine 65 Oral Fingolimod 65 dasatinib 65 tamoxifen citrate 65 immunostimulatory 65 romiplostim 65 Diffuse Large B 65 Doxil 65 ChronVac C R 65 NAVISTAR R 65 Elitek 65 Treatment Naïve 65 chlorambucil 65 immunomodulatory 65 flavopiridol 65 TACE 65 CDK inhibitor 65 sunitinib Sutent 65 Elagolix 65 Tyrosine Kinase Inhibitors 65 Factor Receptor 65 Copegus R 65 adalimumab 65 posaconazole 65 immunotherapeutic agent 65 selective inhibition 65 ISF# 65 ACTEMRA TM 65 Rifampin 65 amikacin 65 Linaclotide 65 Romidepsin 65 GHRH 65 follicular NHL 65 Tarceva erlotinib 65 IMiDs ® compound 65 alteplase 65 refractory metastatic 65 See CLINICAL PHARMACOLOGY 65 Cyclooxygenase 2 65 COPEGUS 65 Elvitegravir 65 Ixabepilone 65 Demonstrates Potent 65 cytotoxic chemotherapy 65 hormone LHRH antagonist 65 trastuzumab Herceptin R 65 pegylated interferon alfa 2b 65 Metastatic 65 Myelofibrosis 65 CD3 monoclonal antibody 65 ADP receptor antagonist 65 REVLIMID ® 65 Non Responders 65 Relapsing Multiple Sclerosis 65 amifostine 65 immunomodulator 65 Dalbavancin 65 ® lenalidomide 65 pharmacokinetic interactions 65 EZN 65 ZACTIMA 65 GnRH agonist 65 calcineurin inhibitors 65 xenograft models 65 Annamycin 65 Talabostat 65 vinorelbine tartrate 65 standard chemotherapy regimens 65 TG# [003] 65 plus dexamethasone 65 Peg IFN 65 Daclizumab 65 Taxotere R 65 LANTUS ® 65 intratumoral 65 Gleevec imatinib 65 dexamethasone Decadron 65 Tolerability 65 non peptidic protease 65 Elderly Patients 65 immunoconjugate 65 pomalidomide 65 CYP#A# inhibitors 65 antibody MAb 65 MEK inhibitor 65 TLK# 65 nucleotide analogue 65 eniluracil 65 lapatinib 65 Statin Therapy 65 Omalizumab 65 CIPN 65 zoledronate 65 Phase IIb Clinical Trial 65 HMG CoA reductase inhibitors 65 infusional 5-FU/LV 65 gemtuzumab ozogamicin 65 mecamylamine 65 ORENCIA R 65 Improves Outcomes 65 oral antiviral 65 lanreotide 65 MYDICAR ® 65 Long Term Efficacy 65 Hypercholesterolemia 65 nicardipine 65 ENMD # 65 Bazedoxifene 65 VNP#M 65 II Clinical Trial 65 Hematopoietic 65 microtubule targeting 65 Seliciclib 65 Mepact 65 Pivotal Phase III 65 Diabetic Neuropathy 65 Entecavir 65 Cimzia R 65 canakinumab 65 ISENTRESS 65 Telaprevir 65 gastrointestinal stromal tumors 65 Rituxan rituximab 65 investigational humanized monoclonal antibody 65 PROMACTA 64 antiangiogenic agents 64 Patients Treated 64 cyclophosphamide Cytoxan 64 Enoxaparin 64 Proxinium TM 64 depsipeptide 64 HER2 ErbB2 64 Nitazoxanide 64 TORISEL 64 metastatic RCC 64 Virulizin ® 64 Ecallantide 64 d4T stavudine Zerit 64 Dendritic Cells 64 tenofovir Viread 64 allogeneic stem cell 64 platinum refractory 64 Ridaforolimus 64 Ophena 64 cancer immunotherapies 64 GAMMAGARD 64 efavirenz EFV 64 Bavituximab 64 CYT# QbG# 64 androgen independent 64 Alferon N 64 Retreatment 64 TREANDA 64 FUSILEV ® 64 TNFa 64 Tiuxetan 64 bortezomib Velcade R 64 intratumoral injection 64 Safinamide 64 Ceflatonin 64 taxane chemotherapy 64 CBLC# 64 QuadraSphere 64 effector function 64 rosuvastatin #mg 64 Archexin 64 VELCADE melphalan 64 rFVIIa 64 immunomodulating 64 Investigational Compound 64 ON #.Na 64 Octreotide 64 paclitaxel poliglumex 64 PROCRIT ® 64 SERMs 64 azoles 64 tamoxifen Nolvadex ® 64 vincristine doxorubicin 64 immune modulating 64 Granulocyte Colony Stimulating Factor 64 chemotherapy FOLFOX 64 farletuzumab 64 Cyclosporine 64 omega interferon 64 PLX# 64 Vicriviroc 64 Humanized Anti 64 Betaferon ® 64 Vimpat R 64 neoadjuvant therapy 64 Myocet 64 Taxane 64 Losartan 64 paricalcitol 64 intravesical 64 VEGFR2 64 ARIMIDEX 64 INCB# [003] 64 intradermal injection 64 radezolid 64 bortezomib Velcade ® 64 Zarnestra 64 Thiarabine 64 cisplatin resistant 64 SUTENT 64 Gleevec Glivec 64 endothelin receptor antagonists 64 radiation sensitizer 64 Certolizumab pegol 64 Subcutaneous 64 raloxifene Evista 64 Parathyroid Hormone 64 PDGFR 64 Immunomodulatory 64 huN# DM1 64 Ambrisentan 64 Xcellerated T Cells 64 molecularly targeted 64 PROCHYMAL 64 RAPAFLO 64 BRIM2 64 HER2 overexpression 64 alpha interferons 64 lamivudine 3TC 64 alpha folate receptor 64 NOXAFIL 64 DUROS 64 Myelodysplastic Syndrome 64 adjuvant radiotherapy 64 Novartis Gleevec 64 EGFR tyrosine kinase inhibitors 64 Eluting Stent 64 Telmisartan 64 PegIntron 64 Temozolomide 64 Bivalirudin 64 rFSH 64 veltuzumab 64 Renal Insufficiency 64 histone deacetylase HDAC inhibitor 64 SPIRIVA ® 64 gonadotropin releasing hormone GnRH 64 achieved CCyR 64 bicalutamide 64 Leucovorin 64 Palonosetron 64 uricase 64 fludarabine cyclophosphamide 64 gemcitabine chemotherapy 64 Filgrastim 64 imatinib therapy 64 VA# [002] 64 Invasive Fungal Infections 64 cutaneous T 64 metaglidasen 64 HyACT 64 Avastin bevacizumab 64 Protease Inhibitor 64 ganciclovir 64 RAPAMUNE 64 Efudex 64 Telintra 64 amphotericin B 64 Retinoic Acid 64 fluvastatin 64 low dose cytarabine 64 angiotensin receptor blocker ARB 64 Milatuzumab 64 pimecrolimus 64 Celecoxib 64 Paclitaxel 64 MEK Inhibitor 64 plasma kallikrein inhibitor 64 IV Busulfex